Faut-il prescrire les anti-inflammatoires non stéroïdiens à visée ...

Faut-il prescrire les anti-inflammatoires non stéroïdiens à visée ... Faut-il prescrire les anti-inflammatoires non stéroïdiens à visée ...

bichat.larib.com
from bichat.larib.com More from this publisher
22.06.2013 Views

VI) Bibliographie [1] Karen I. Plaisance, MD; Philip A. Mackowiak, MD. Antipyretic therapy : physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med Vol 160, Feb 28, 2000 ; 160:449-456 [2] National Collaborating Centre for Women’s and Children’s Health . Feverish illness in children : assessment and initial management in children younger than 5 years . Clinical Guideline commissioned by the National Institute for Health and Clinical Excellence, May 2007 [3] IUPS Thermal Commission. Glossery of terms for Thermal Physiology. 2 nd ed. Pflügers Arch 1987;410:567-587. [4] Paul L. McCarthy, Gordon W. Grundy, Sydney Z. Spiesel, Thomas F. Dolan Jr. Bacteremia in children: An outpatient clinical review. Pediatrics Vol. 57 No. 6 June 1976, pp. 861-868 [5] Mazur LJ, Jones TM, Kozinetz CA Temperature response to acetaminophen and risk of occult bacteremia: A case-control study. J Pediatr. 1989 ; 115:888-891 [6] Timothy F. Doran, Catherine De Angelis, Rosemary A. Baumgardner, E. David Mellits Acetaminophen: More harm than good for chickenpox? The Journal of Pediatrics - June 1989 (Vol. 114, Issue 6, Pages 1045-1048) [7] Stanley E, Jackson GG, Panusarn C, Rubenis M, Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA. 1975;231:1248–1251 [8] Neil M. H. Graham, Christopher J. Burrell, Robert M. Douglas, Pamela Debelle and Lorraine Davies Adverse effects of Aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in Rhinovirus-infected volunteers. J Infect Dis, 1990, 162(6): 1277-1282 [9] Brandts CH, Ndjavé M, Graninger W, Kremsner PG Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. 1997 Sep 6;350(9079):704-9. [10] Prymula R., Siegrist C.A., Chlibek R., Zemlickova H., Vackova M., Smetana J. et al Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children : two open-label, randomised controlled trials Lancet, 2009, 374 : 1339-1350 [11] C Waruiru, R Appleton. Febrile seizures: an update. Arch Dis Child 2004;89:751–756 [12] van Stuijvenberg M, Derksen-Lubsen G, Steyerberg EW, Habbema JD, Moll HA. Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile seizure recurrences. Pediatrics. 1998 Nov;102(5):E51. [13] Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, Rantala H. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch Pediatr Adolesc Med. 2009 Sep;163(9):799-804. [14] James G. Heida, Solomon L. Moshé and Quentin J. Pittman The role of interleukin-1β in febrile seizures Brain Dev. 2009 May ; 31(5): 388–393 [15] Ngwane E, Bower B. Continuous sodium valproate or phenobarbitone in the 98

prevention of 'simple' febrile convulsions. Comparison by a double-blind trial. Arch Dis Child. 1980 Mar;55(3):171-4 [16] Uhari M, Rantala H, Vainionpaa L, Kurttila R. Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatr 1995;126:991–5. [17] Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM, Van Bennekom C, Winter MR. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med. 1993 Jul 8;329(2):79-84. [18] Bégué P. et Astruc J. Pathologie infectieuse de l'enfant, p.7, 2è éd. Masson, Paris, 1999, ISBN 2-225-83669-8 [19] Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs. Nature 1971 ; 231 : 232-5. [20] J F T Glasgow, B Middleton Reye syndrome—insights on causation and prognosis . Arch Dis Child 2001;85:351–353 [21] Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999 May 6;340(18):1377-82 [22] Orlowski JP, Hanhan UA, Fiallos MR. Is aspirin a cause of Reye's syndrome? A case against. Drug Saf. 2002;25(4):225-31 [23] Orlowski JP. Whatever happened to Reye's syndrome? Did it ever really exist? Crit Care Med. 1999 Aug;27(8):1582-7. [24] Autret-Leca E, Jonville-Béra AP, Llau ME, Bavoux F, Saudubray JM & al. Incidence of Reye's syndrome in France: a hospital-based survey. J Clin Epidemiol. 2001 Aug;54(8):857-62 [25] Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 2000 Oct;31 Suppl 5:S202-10 [26] Charkaluk ML, Kalach N et al. Familial use of ibuprofen in febrile children: a prospective study in the emergency room of an hospital in Lille. Arch Pediatr. 2005 Aug;12(8):1209-14 [27] Annie Mars, Les panels: outils incontournables des études de marché dans l'industrie, p.148, Paris : Heures de France, 2005. ISBN 2-85385-260-1 [28] Moore N. Ibuprofen: a journey from prescription to over-the-counter use. J R Soc Med. 2007;100 Suppl 48:2-6. [29]Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009 Dec;17(6):275-342. [30] Langman MJ, Weil J, Wainwright P & al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994 Apr 30;343(8905):1075-8. [31] Campbell KL, De Beaux AC. Non-steroidal anti-inflammatory drugs and appendicitis in patients aged over 50 years. Br J Surg. 1992 Sep;79(9):967-8. [32]Goh H, Bourne R. Non-steroidal anti-inflammatory drugs and perforated diverticular 99

VI) Bibliographie<br />

[1] Karen I. Plaisance, MD; Ph<strong>il</strong>ip A. Mackowiak, MD. Antipyretic therapy : physiologic<br />

rationale, diagnostic implications, and clinical consequences. Arch Intern Med Vol 160,<br />

Feb 28, 2000 ; 160:449-456<br />

[2] National Collaborating Centre for Women’s and Ch<strong>il</strong>dren’s Health . Feverish <strong>il</strong>lness in<br />

ch<strong>il</strong>dren : assessment and initial management in ch<strong>il</strong>dren younger than 5 years . Clinical<br />

Guideline commissioned by the National Institute for Health and Clinical Excellence, May<br />

2007<br />

[3] IUPS Thermal Commission. Glossery of terms for Thermal Physiology. 2 nd ed. Pflügers<br />

Arch 1987;410:567-587.<br />

[4] Paul L. McCarthy, Gordon W. Grundy, Sydney Z. Spiesel, Thomas F. Dolan Jr.<br />

Bacteremia in ch<strong>il</strong>dren: An outpatient clinical review. Pediatrics Vol. 57 No. 6 June 1976,<br />

pp. 861-868<br />

[5] Mazur LJ, Jones TM, Kozinetz CA Temperature response to acetaminophen and risk of<br />

occult bacteremia: A case-control study. J Pediatr. 1989 ; 115:888-891<br />

[6] Timothy F. Doran, Catherine De Angelis, Rosemary A. Baumgardner, E. David Mellits<br />

Acetaminophen: More harm than good for chickenpox? The Journal of Pediatrics - June<br />

1989 (Vol. 114, Issue 6, Pages 1045-1048)<br />

[7] Stanley E, Jackson GG, Panusarn C, Rubenis M, Dirda V. Increased virus shedding<br />

with aspirin treatment of rhinovirus infection. JAMA. 1975;231:1248–1251<br />

[8] Ne<strong>il</strong> M. H. Graham, Christopher J. Burrell, Robert M. Douglas, Pamela Debelle and<br />

Lorraine Davies Adverse effects of Aspirin, acetaminophen, and ibuprofen on immune<br />

function, viral shedding, and clinical status in Rhinovirus-infected volunteers. J Infect Dis,<br />

1990, 162(6): 1277-1282<br />

[9] Brandts CH, Ndjavé M, Graninger W, Kremsner PG Effect of paracetamol on parasite<br />

clearance time in Plasmodium falciparum malaria. Lancet. 1997 Sep 6;350(9079):704-9.<br />

[10] Prymula R., Siegrist C.A., Chlibek R., Zemlickova H., Vackova M., Smetana J. et al<br />

Effect of prophylactic paracetamol administration at time of vaccination on febr<strong>il</strong>e<br />

reactions and <strong>anti</strong>body responses in ch<strong>il</strong>dren : two open-label, randomised controlled<br />

trials Lancet, 2009, 374 : 1339-1350<br />

[11] C Waruiru, R Appleton. Febr<strong>il</strong>e seizures: an update. Arch Dis Ch<strong>il</strong>d 2004;89:751–756<br />

[12] van Stuijvenberg M, Derksen-Lubsen G, Steyerberg EW, Habbema JD, Moll HA.<br />

Randomized, controlled trial of ibuprofen syrup administered during febr<strong>il</strong>e <strong>il</strong>lnesses to<br />

prevent febr<strong>il</strong>e seizure recurrences. Pediatrics. 1998 Nov;102(5):E51.<br />

[13] Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, Rantala H. Antipyretic<br />

agents for preventing recurrences of febr<strong>il</strong>e seizures: randomized controlled trial. Arch<br />

Pediatr Ado<strong>les</strong>c Med. 2009 Sep;163(9):799-804.<br />

[14] James G. Heida, Solomon L. Moshé and Quentin J. Pittman The role of interleukin-1β<br />

in febr<strong>il</strong>e seizures Brain Dev. 2009 May ; 31(5): 388–393<br />

[15] Ngwane E, Bower B. Continuous sodium valproate or phenobarbitone in the<br />

98

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!